[1-[3-(4-methylpyridin-1-ium-1-yl)propyl]pyridin-4-ylidene]methyl-oxoazanium,dibromide

Names

[ CAS No. ]:
25892-74-4

[ Name ]:
[1-[3-(4-methylpyridin-1-ium-1-yl)propyl]pyridin-4-ylidene]methyl-oxoazanium,dibromide

[Synonym ]:
R 84
4-Formyl-4'-methyl-1,1'-trimethylenebis(pyridinium bromide) oxime
Pyridinium,4-formyl-4'-methyl-1,1'-trimethylenedi-,dibromide,oxime
BDB 20
4-(hydroxyimino-methyl)-4'-methyl-1,1'-propanediyl-bis-pyridinium,dibromide
Pyridinium,4-((hydroxyimino)methyl)-1-(3-(4-methylpyridinio)propyl)-,dibromide
4-(Hydroxyimino-methyl)-4'-methyl-1,1'-propandiyl-bis-pyridinium,Dibromid
4-((Hydroxyimino)methyl)-1-(3-(4-methylpyridinio)propyl)pyridinium dibromide
[1-[3-(4-methylpyridin-1-ium-1-yl)propyl]pyridin-4-ylidene]methyl-oxoazanium dibromide

Chemical & Physical Properties

[ Molecular Formula ]:
C15H19Br2N3O

[ Molecular Weight ]:
417.13900

[ Exact Mass ]:
414.98900

[ PSA ]:
38.24000

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UU5216000
CHEMICAL NAME :
Pyridinium, 4-((hydroxyimino)methyl)-1-(3-(4-methylpyridinio)prop yl)-, dibromide
CAS REGISTRY NUMBER :
25892-74-4
LAST UPDATED :
199606
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C15-H19-N3-O.2Br

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BJPCAL British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For publisher information, see BJPCBM. Volume(issue)/page/year: 14,186,1959

Synthetic Route


Related Compounds

  • 2-[(2-{2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-1,3-thiazol-4-yl}acetamido)methyl]cyclopropane-1-carboxylic acid
  • 2-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(1,3-thiazol-5-yl)propanamido]methyl}cyclopropane-1-carboxylic acid
  • 2-{[(3R)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]methyl}cyclopropane-1-carboxylic acid
  • 2-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(1H-pyrrol-2-yl)propanamido]methyl}cyclopropane-1-carboxylic acid
  • rac-(2R,3S)-3-{3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-difluorocyclopropaneamido}oxolane-2-carboxylic acid
  • 3-{3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-difluorocyclopropaneamido}cyclobutane-1-carboxylic acid
  • (4R)-3-[(1RS,3SR)-3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-difluorocyclopropanecarbonyl]-1,3-thiazolidine-4-carboxylic acid
  • rac-3-[(1R,3S)-3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-difluorocyclopropanecarbonyl]-1,3-thiazolidine-4-carboxylic acid
  • rac-4-[(1R,3S)-3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,2-difluorocyclopropanecarbonyl]thiomorpholine-2-carboxylic acid
  • 3-(1-{2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopropanecarbonyl}piperidin-3-yl)propanoic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.